• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Wednesday, January 20, 2021
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

TalTech’s neuroscientists investigate the causes of a widespread eye disease

Bioengineer by Bioengineer
January 13, 2021
in Health
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: TalTech

Fuchs’ corneal dystrophy is one of the most common eye diseases diagnosed in almost 5% of the population of Europe aged 40 years or over. It is a hereditary eye disease that causes vision impairment and typically manifests in middle age. The first symptoms of the disease – blisters on the surface of your cornea – resemble cataract at first glance. The disease progresses from the centre of the cornea affecting all layers of the cornea. The progression of the disease varies from individual to individual and in severe cases results in vision loss.

The molecular neurobiology research group led by Professor of Molecular Biology Tõnis Timmusk published an article about Fuchs’ dystrophy in the journal Scientific Reports titled “The Fuchs corneal dystrophy-associated CTG repeat expansion in the TCF4 gene affects transcription from its alternative promoters”, authored by Alex Sirp, Kristian Leite, Jürgen Tuvikene, Kaja Nurm, Mari Sepp and Tõnis Timmusk.

Professor Timmusk says, “Currently, the only method used to treat Fuchs’ corneal dystrophy is a surgical procedure, in the course of which the patient’s whole cornea is replaced. However, such a treatment is complicated because it requires availability of donor tissue. To prevent an unpleasant surgical procedure, we are working to better understand the causes of Fuchs’ dystrophy and to find ways to prevent it.”

The human genome – DNA – is composed of chains of four different types of nucleotides (abbreviated A, T, C and G). Their different combinations make us actually who we are. Repeated sequences occur in DNA, i.e. some combinations in our genome can be repeated tens or hundreds or even thousands of times. Such repeats are unstable, varying in length between individuals as well as in different tissues of the same individual.

“Expansion of certain repeats can cause repeat expansion diseases. In most cases, such diseases are caused by abnormal repeat expansion of three nucleotides, which is why they are known also as trinucleotide repeat disorders,” says one of the lead authors of the article, PhD student Alex Sirp.

Trinucleotide repeat disorders are a set of over 40 different disorders, including Huntington’s disease, fragile X syndrome, myotonic dystrophy, etc. The Fuchs’ endothelial corneal dystrophy is caused by the CTG trinucleotide repeat expansion in Transcription factor 4 (TCF4). While the repeat length in healthy persons remains below 40, the repeat length in persons with visual impairment is above 40 repeats. “TCF4 gene pays an important role in the development and functioning of the human nervous system. Mutations and variations in TCF4 are directly associated with schizophrenia, mental retardation and a very rare disorder called Pitt-Hopkins Syndrome, ” says Sirp.
Tõnis Timmusk says, “The results of our study showed that CTG repeat expansion affects the expression of TCF4 in cultured cells. Due to rapid advances in genomic technologies in recent years, we were able to compare expression of the TCF4 gene in the corneal endothelium of healthy persons and patients with Fuchs’ dystrophy. The results revealed changes in TCF4 expression levels in case of Fuchs’ endothelial corneal dystrophy.

The findings of the research help to understand how these (tri)nucleotide repeats can affect development of a disease through changes in gene expression. These results may also contribute to the development of drugs for the treatment of Fuchs’ dystrophy.

“As a next step, we want to determine when and for how long changes in TCF4 level occur in people who later develop Fuchs’ endothelial corneal dystrophy. This would make it possible to develop a treatment strategy that would enable regulation of TCF4 levels in the corneal endothelium and thus prevent the disease,” says Professor Timmusk.

###

Source:
Scientific Reports article titled “The Fuchs corneal dystrophy-associated CTG repeat expansion in the TCF4 gene affects transcription from its alternative promoters” 28.10.2020
https://www.nature.com/articles/s41598-020-75437-3

Additional information:
Professor at TalTech Department of Chemistry and Biotechnology, Division of Gene Technology Tõnis Timmusk,
[email protected]
and
Early Stage Researcher Alex Sirp,
[email protected]

Kersti Vähi, TalTech Research Administration Office

Media Contact
Tõnis Timmusk
[email protected]

Related Journal Article

http://dx.doi.org/10.1038/s41598-020-75437-3

Tags: Medicine/Healthneurobiology
Share12Tweet8Share2ShareShareShare2

Related Posts

IMAGE

Genome editing to treat human retinal degeneration

January 19, 2021
IMAGE

Individual and organizational capacity to change can reduce health care workforce burnout

January 19, 2021

Brain cell network supplies neurons with energy

January 19, 2021

Lack of physical exercise during COVID-19 confinement may lead to a rise in mortality

January 19, 2021
Next Post
IMAGE

Lipid biomarkers in urine can determine the type of asthma

IMAGE

New studies support blood test for early detection of Alzheimer's disease

Leave a Reply Cancel reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

POPULAR NEWS

  • IMAGE

    The map of nuclear deformation takes the form of a mountain landscape

    54 shares
    Share 22 Tweet 14
  • New drug form may help treat osteoporosis, calcium-related disorders

    40 shares
    Share 16 Tweet 10
  • People living with HIV face premature heart disease and barriers to care

    60 shares
    Share 24 Tweet 15
  • Blood pressure drug may be key to increasing lifespan, new study shows

    44 shares
    Share 18 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Tags

GeneticsChemistry/Physics/Materials SciencesMedicine/HealthCell BiologyClimate ChangePublic HealthcancerBiologyTechnology/Engineering/Computer ScienceEcology/EnvironmentInfectious/Emerging DiseasesMaterials

Recent Posts

  • Breakthrough in understanding ‘tummy bug’ bacteria
  • Stealing the spotlight in the field and kitchen
  • Genome editing to treat human retinal degeneration
  • Do simulations represent the real world at the atomic scale?
  • Contact Us

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In